PATENT CLAIM ANALYSIS

Application Number: 15893861
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "682000"]

Abstract:
The present invention provides, among other things, compositions and methods suitable for the treatment of hyperphosphatemia based on phosphate-binding magnesium salts. In some embodiments, the present invention provides compositions and methods suitable for the treatment of hyperphosphatemia based on the combination of phosphate-binding magnesium and calcium salts.

Claim (Index 110):
The composition of  claim 107 , further comprising at least one calcium salt.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 88.0
- Lexical Diversity: 1.85714
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15477325', '15155366', '12422012', '13445771', '13856084']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7530149129972699
- 35 USC 102 Novelty (BERT): 0.5601245539379843
- Combined Prediction Score: 0.7337258770913413
- Mean Citation Score: 413.804244
- Max Citation Score: 436.84155
- Similarity Product: 342.59630155154764

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test